Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
+$0.07 today
- Market cap
- $332.70M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
Volume 0.26M
Average 0.26M
VMD Total Current Assets
All assets expected to be converted to cash or used up within one year.
Viemed Healthcare, Inc.NASDAQ: VMD
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets broadly unchanged from a year ago
Total current assets stood at $49.81M at the end of Q1 FY2026, up 1.4% from a year earlier and up 2.7% from the prior quarter. Over 3 fiscal years it compounded at +6.9% a year.
Context
- Total current assets amounted to 25.2% of total assets at the end of Q1 FY2026, down 2.3 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +1.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 48.49M USD
- Year-over-year change
- -8.3%
- 4-year CAGR
- +0.6%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 48.49M | -8.3% |
| FY2024 | 2024-12-31 | 52.88M | +37.8% |
| FY2023 | 2023-12-31 | 38.37M | -3.5% |
| FY2022 | 2022-12-31 | 39.74M | -16.0% |
| FY2021 | 2021-12-31 | 47.31M | — |
Total Current Assets vs competitors
How VMD compares with its peers on the latest reported figures
- VMD's Mar 2026 total current assets of $49.81M is the 10th highest of the 11 companies compared; the peer median is $101.63M.
- Its year-over-year change of +1.4% is the 4th highest of 11, against a peer median of -10.1%.
- Total current assets amounts to 25.2% of total assets for VMD, versus a peer median of 80.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $236.71M | -17.4% | -12.4% | 94.9% | |
| Mar 2026 | $190.67M | -5.0% | -13.3% | 66.7% | |
| Mar 2026 | $185.73M | -44.6% | -17.8% | 50.7% | |
| Mar 2026 | $142.01M | -4.7% | -12.5% | 76.1% | |
| Mar 2026 | $106.51M | -16.1% | -18.7% | 97.1% | |
| Mar 2026 | $96.75M | -23.3% | -6.1% | 97.0% | |
| Mar 2026 | $92.28M | +17.7% | -10.0% | 89.7% | |
| Dec 2025 | $66.79M | -15.1% | -6.8% | 41.2% | |
| Mar 2026 | $50.23M | +13.7% | +9.3% | 84.5% | |
| Mar 2026 | $49.81M | +1.4% | +6.9% | 25.2% | |
| Mar 2026 | $23.96M | +27.2% | +54.9% | 64.6% | |
| Peer median (excluding VMD) | $101.63M | -10.1% | -11.2% | 80.3% | |
Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.41M | 16.91M | 12.84M | 17.54M | 13.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.72M | 15.41M | 18.45M | 24.91M | 25.59M |
| Inventory | 2.46M | 3.57M | 4.63M | 4.32M | 5.05M |
| Other Current Assets | 0 | 3.85M | 2.45M | 6.11M | 4.36M |
| Total Current Assets | 47.31M | 39.74M | 38.37M | 52.88M | 48.49M |
| Property, Plant & Equipment (Net) | 62.85M | 68.44M | 76.85M | 79.16M | 82.36M |
| Goodwill | 0 | 0 | 29.77M | 32.99M | 58.94M |
| Intangible Assets | 0 | 0 | 567K | 848K | 1.29M |
| Long-term Investments | 2.16M | 4.16M | 3.9M | 2.79M | 2.79M |
| Tax Assets | 4.79M | 3.12M | 4.56M | 8.4M | 5.29M |
| Other Non-current Assets | 862K | 1.59M | 887K | 0 | 15.79M |
| Total Non-current Assets | 70.65M | 77.3M | 116.53M | 124.19M | 166.45M |
| Total Assets | 117.96M | 117.04M | 154.9M | 177.07M | 214.94M |
| Account Payables | 5.25M | 4.9M | 7.41M | 9.34M | 12.33M |
| Short-term Debt | 1.48M | 0 | 1.07M | 409K | 1.09M |
| Tax Payables | 0 | 0 | 2.15M | 3.88M | 0 |
| Deferred Revenue | 3.75M | 4.62M | 6.21M | 6.69M | 7.52M |
| Other Current Liabilities | 2.34M | 3.19M | 6.52M | 5.1M | 6.3M |
| Total Current Liabilities | 17.81M | 18.86M | 32.12M | 37.33M | 41.06M |
| Long-term Debt | 4.31M | 0 | 6M | 3.59M | 11.29M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 15.79M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 757K | 889K | 558K | 846K | 922K |
| Total Non-current Liabilities | 5.33M | 1.09M | 8.88M | 6.44M | 30.37M |
| Total Liabilities | 23.14M | 19.95M | 41M | 43.77M | 71.42M |
| Common Stock | 14.01M | 15.12M | 18.7M | 23.37M | 16.91M |
| Retained Earnings | 73.34M | 69.85M | 79.5M | 89.69M | 102.89M |
| Accumulated OCI | (278K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 1.91M | 1.98M |
| Total Equity | 94.82M | 97.09M | 113.9M | 133.3M | 143.52M |
| Total Debt | 6.52M | 694K | 10.32M | 6.87M | 15.95M |
| Net Debt | (21.89M) | (16.22M) | (2.52M) | (10.67M) | 2.45M |
Viemed Healthcare, Inc.
NASDAQ:VMD
Intrinsic Alpha fair value
Locked
Current Price
$8.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.